IBDEI065 ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8212,1,3,0)
 ;;=3^Malig Neopl of Eyeball,Iris
 ;;^UTILITY(U,$J,358.3,8212,1,4,0)
 ;;=4^190.0
 ;;^UTILITY(U,$J,358.3,8212,2)
 ;;=Malig Neopl of Iris^267271
 ;;^UTILITY(U,$J,358.3,8213,0)
 ;;=190.3^^53^571^83
 ;;^UTILITY(U,$J,358.3,8213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8213,1,3,0)
 ;;=3^Malig Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,8213,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,8213,2)
 ;;=Malig Neopl Conjunctiva^267274
 ;;^UTILITY(U,$J,358.3,8214,0)
 ;;=364.41^^53^571^50
 ;;^UTILITY(U,$J,358.3,8214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8214,1,3,0)
 ;;=3^Hyphema
 ;;^UTILITY(U,$J,358.3,8214,1,4,0)
 ;;=4^364.41
 ;;^UTILITY(U,$J,358.3,8214,2)
 ;;=Hyphema^60498
 ;;^UTILITY(U,$J,358.3,8215,0)
 ;;=364.05^^53^571^51
 ;;^UTILITY(U,$J,358.3,8215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8215,1,3,0)
 ;;=3^Hypopyon
 ;;^UTILITY(U,$J,358.3,8215,1,4,0)
 ;;=4^364.05
 ;;^UTILITY(U,$J,358.3,8215,2)
 ;;=Hypopion^60720
 ;;^UTILITY(U,$J,358.3,8216,0)
 ;;=365.02^^53^571^4
 ;;^UTILITY(U,$J,358.3,8216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8216,1,3,0)
 ;;=3^Angle, Narrow
 ;;^UTILITY(U,$J,358.3,8216,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,8216,2)
 ;;=Angle, Narrow^268748
 ;;^UTILITY(U,$J,358.3,8217,0)
 ;;=372.63^^53^571^117
 ;;^UTILITY(U,$J,358.3,8217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8217,1,3,0)
 ;;=3^Symblepharon
 ;;^UTILITY(U,$J,358.3,8217,1,4,0)
 ;;=4^372.63
 ;;^UTILITY(U,$J,358.3,8217,2)
 ;;=Symblepharon^265885
 ;;^UTILITY(U,$J,358.3,8218,0)
 ;;=372.75^^53^571^27
 ;;^UTILITY(U,$J,358.3,8218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8218,1,3,0)
 ;;=3^Cysts, Conjunctival
 ;;^UTILITY(U,$J,358.3,8218,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,8218,2)
 ;;=Cysts, Conjunctival^269049
 ;;^UTILITY(U,$J,358.3,8219,0)
 ;;=364.81^^53^571^43
 ;;^UTILITY(U,$J,358.3,8219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8219,1,3,0)
 ;;=3^Floppy Iris Syndrome
 ;;^UTILITY(U,$J,358.3,8219,1,4,0)
 ;;=4^364.81
 ;;^UTILITY(U,$J,358.3,8219,2)
 ;;=^335254
 ;;^UTILITY(U,$J,358.3,8220,0)
 ;;=006.9^^53^571^2
 ;;^UTILITY(U,$J,358.3,8220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8220,1,3,0)
 ;;=3^Amebiasis
 ;;^UTILITY(U,$J,358.3,8220,1,4,0)
 ;;=4^006.9
 ;;^UTILITY(U,$J,358.3,8220,2)
 ;;=^5818
 ;;^UTILITY(U,$J,358.3,8221,0)
 ;;=190.8^^53^571^60
 ;;^UTILITY(U,$J,358.3,8221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8221,1,3,0)
 ;;=3^Iris Melanoma,Contiguous Site
 ;;^UTILITY(U,$J,358.3,8221,1,4,0)
 ;;=4^190.8
 ;;^UTILITY(U,$J,358.3,8221,2)
 ;;=^267278
 ;;^UTILITY(U,$J,358.3,8222,0)
 ;;=224.1^^53^571^93
 ;;^UTILITY(U,$J,358.3,8222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8222,1,3,0)
 ;;=3^Orbit Neoplasm,Benign
 ;;^UTILITY(U,$J,358.3,8222,1,4,0)
 ;;=4^224.1
 ;;^UTILITY(U,$J,358.3,8222,2)
 ;;=^267671
 ;;^UTILITY(U,$J,358.3,8223,0)
 ;;=360.33^^53^571^52
 ;;^UTILITY(U,$J,358.3,8223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8223,1,3,0)
 ;;=3^Hypotony,Assoc w/ Ocular D/O
 ;;^UTILITY(U,$J,358.3,8223,1,4,0)
 ;;=4^360.33
 ;;^UTILITY(U,$J,358.3,8223,2)
 ;;=^268560
 ;;^UTILITY(U,$J,358.3,8224,0)
 ;;=224.8^^53^571^86
 ;;^UTILITY(U,$J,358.3,8224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8224,1,3,0)
 ;;=3^Neopl Eye Bgn,Oth Iris Nevus
 ;;^UTILITY(U,$J,358.3,8224,1,4,0)
 ;;=4^224.8
 ;;^UTILITY(U,$J,358.3,8224,2)
 ;;=^267678
 ;;^UTILITY(U,$J,358.3,8225,0)
 ;;=364.01^^53^571^103
 ;;^UTILITY(U,$J,358.3,8225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8225,1,3,0)
 ;;=3^Prim Iridocyclitis
 ;;^UTILITY(U,$J,358.3,8225,1,4,0)
 ;;=4^364.01
 ;;^UTILITY(U,$J,358.3,8225,2)
 ;;=^268704
 ;;^UTILITY(U,$J,358.3,8226,0)
 ;;=364.04^^53^571^53
 ;;^UTILITY(U,$J,358.3,8226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8226,1,3,0)
 ;;=3^Iridociclyties 2ary,Non Infectious
 ;;^UTILITY(U,$J,358.3,8226,1,4,0)
 ;;=4^364.04
 ;;^UTILITY(U,$J,358.3,8226,2)
 ;;=^268710
 ;;^UTILITY(U,$J,358.3,8227,0)
 ;;=364.21^^53^571^46
 ;;^UTILITY(U,$J,358.3,8227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8227,1,3,0)
 ;;=3^Fuch's Hetero Cyclitis
 ;;^UTILITY(U,$J,358.3,8227,1,4,0)
 ;;=4^364.21
 ;;^UTILITY(U,$J,358.3,8227,2)
 ;;=^48468
 ;;^UTILITY(U,$J,358.3,8228,0)
 ;;=364.23^^53^571^81
 ;;^UTILITY(U,$J,358.3,8228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8228,1,3,0)
 ;;=3^Lens-Induced Iridocyclitis
 ;;^UTILITY(U,$J,358.3,8228,1,4,0)
 ;;=4^364.23
 ;;^UTILITY(U,$J,358.3,8228,2)
 ;;=^268713
 ;;^UTILITY(U,$J,358.3,8229,0)
 ;;=364.51^^53^571^8
 ;;^UTILITY(U,$J,358.3,8229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8229,1,3,0)
 ;;=3^Atrophy Iris Essential/Progressive
 ;;^UTILITY(U,$J,358.3,8229,1,4,0)
 ;;=4^364.51
 ;;^UTILITY(U,$J,358.3,8229,2)
 ;;=^268718
 ;;^UTILITY(U,$J,358.3,8230,0)
 ;;=364.53^^53^571^100
 ;;^UTILITY(U,$J,358.3,8230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8230,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,8230,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,8230,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,8231,0)
 ;;=364.57^^53^571^33
 ;;^UTILITY(U,$J,358.3,8231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8231,1,3,0)
 ;;=3^Degen Ciliary Body Changes
 ;;^UTILITY(U,$J,358.3,8231,1,4,0)
 ;;=4^364.57
 ;;^UTILITY(U,$J,358.3,8231,2)
 ;;=^268728
 ;;^UTILITY(U,$J,358.3,8232,0)
 ;;=364.60^^53^571^26
 ;;^UTILITY(U,$J,358.3,8232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8232,1,3,0)
 ;;=3^Cyst,Idiopathic
 ;;^UTILITY(U,$J,358.3,8232,1,4,0)
 ;;=4^364.60
 ;;^UTILITY(U,$J,358.3,8232,2)
 ;;=^268733
 ;;^UTILITY(U,$J,358.3,8233,0)
 ;;=364.73^^53^571^97
 ;;^UTILITY(U,$J,358.3,8233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8233,1,3,0)
 ;;=3^Peripheral Ant Synechiae
 ;;^UTILITY(U,$J,358.3,8233,1,4,0)
 ;;=4^364.73
 ;;^UTILITY(U,$J,358.3,8233,2)
 ;;=^268740
 ;;^UTILITY(U,$J,358.3,8234,0)
 ;;=364.75^^53^571^107
 ;;^UTILITY(U,$J,358.3,8234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8234,1,3,0)
 ;;=3^Pupillary Abnormalities
 ;;^UTILITY(U,$J,358.3,8234,1,4,0)
 ;;=4^364.75
 ;;^UTILITY(U,$J,358.3,8234,2)
 ;;=^268742
 ;;^UTILITY(U,$J,358.3,8235,0)
 ;;=364.76^^53^571^58
 ;;^UTILITY(U,$J,358.3,8235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8235,1,3,0)
 ;;=3^Iridodialysis
 ;;^UTILITY(U,$J,358.3,8235,1,4,0)
 ;;=4^364.76
 ;;^UTILITY(U,$J,358.3,8235,2)
 ;;=^265499
 ;;^UTILITY(U,$J,358.3,8236,0)
 ;;=364.77^^53^571^3
 ;;^UTILITY(U,$J,358.3,8236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8236,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,8236,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,8236,2)
 ;;=^268743
 ;;^UTILITY(U,$J,358.3,8237,0)
 ;;=364.89^^53^571^62
 ;;^UTILITY(U,$J,358.3,8237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8237,1,3,0)
 ;;=3^Iris/Ciliary D/O,Other
 ;;^UTILITY(U,$J,358.3,8237,1,4,0)
 ;;=4^364.89
 ;;^UTILITY(U,$J,358.3,8237,2)
 ;;=^268745
 ;;^UTILITY(U,$J,358.3,8238,0)
 ;;=364.9^^53^571^61
 ;;^UTILITY(U,$J,358.3,8238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8238,1,3,0)
 ;;=3^Iris/Ciliary Body D/O,Unspec
 ;;^UTILITY(U,$J,358.3,8238,1,4,0)
 ;;=4^364.9
 ;;^UTILITY(U,$J,358.3,8238,2)
 ;;=^123847
 ;;^UTILITY(U,$J,358.3,8239,0)
 ;;=370.00^^53^571^25
 ;;^UTILITY(U,$J,358.3,8239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8239,1,3,0)
 ;;=3^Corneal Ulcer NOS
 ;;^UTILITY(U,$J,358.3,8239,1,4,0)
 ;;=4^370.00
 ;;^UTILITY(U,$J,358.3,8239,2)
 ;;=^28441
 ;;^UTILITY(U,$J,358.3,8240,0)
 ;;=370.20^^53^571^66
 ;;^UTILITY(U,$J,358.3,8240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8240,1,3,0)
 ;;=3^Keratitis,Superfic Unspec
 ;;^UTILITY(U,$J,358.3,8240,1,4,0)
 ;;=4^370.20
 ;;^UTILITY(U,$J,358.3,8240,2)
 ;;=^268918
 ;;^UTILITY(U,$J,358.3,8241,0)
 ;;=370.31^^53^571^99
 ;;^UTILITY(U,$J,358.3,8241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8241,1,3,0)
 ;;=3^Phlyctenule Keratoconj
 ;;^UTILITY(U,$J,358.3,8241,1,4,0)
 ;;=4^370.31
 ;;^UTILITY(U,$J,358.3,8241,2)
 ;;=^268928^017.30
 ;;^UTILITY(U,$J,358.3,8242,0)
 ;;=370.8^^53^571^65
 ;;^UTILITY(U,$J,358.3,8242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8242,1,3,0)
 ;;=3^Keratitis,Oth Forms
 ;;^UTILITY(U,$J,358.3,8242,1,4,0)
 ;;=4^370.8
 ;;^UTILITY(U,$J,358.3,8242,2)
 ;;=^87595
 ;;^UTILITY(U,$J,358.3,8243,0)
 ;;=371.24^^53^571^23
 ;;^UTILITY(U,$J,358.3,8243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8243,1,3,0)
 ;;=3^Corneal Edema,Sec Contact Lens
 ;;^UTILITY(U,$J,358.3,8243,1,4,0)
 ;;=4^371.24
 ;;^UTILITY(U,$J,358.3,8243,2)
 ;;=^268969
 ;;^UTILITY(U,$J,358.3,8244,0)
 ;;=371.46^^53^571^88
 ;;^UTILITY(U,$J,358.3,8244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8244,1,3,0)
 ;;=3^Nodular Degeneration
 ;;^UTILITY(U,$J,358.3,8244,1,4,0)
 ;;=4^371.46
 ;;^UTILITY(U,$J,358.3,8244,2)
 ;;=^268981
 ;;^UTILITY(U,$J,358.3,8245,0)
 ;;=371.48^^53^571^98
 ;;^UTILITY(U,$J,358.3,8245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8245,1,3,0)
 ;;=3^Peripheral Degeneration
 ;;^UTILITY(U,$J,358.3,8245,1,4,0)
 ;;=4^371.48
 ;;^UTILITY(U,$J,358.3,8245,2)
 ;;=^268982
 ;;^UTILITY(U,$J,358.3,8246,0)
 ;;=371.49^^53^571^34
 ;;^UTILITY(U,$J,358.3,8246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8246,1,3,0)
 ;;=3^Degeneration,Other
 ;;^UTILITY(U,$J,358.3,8246,1,4,0)
 ;;=4^371.49
 ;;^UTILITY(U,$J,358.3,8246,2)
 ;;=^268983
 ;;^UTILITY(U,$J,358.3,8247,0)
 ;;=371.52^^53^571^18
 ;;^UTILITY(U,$J,358.3,8247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8247,1,3,0)
 ;;=3^Cornea Dystrophy,Anterior Other
 ;;^UTILITY(U,$J,358.3,8247,1,4,0)
 ;;=4^371.52
 ;;^UTILITY(U,$J,358.3,8247,2)
 ;;=^268985
 ;;^UTILITY(U,$J,358.3,8248,0)
 ;;=371.53^^53^571^47
 ;;^UTILITY(U,$J,358.3,8248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8248,1,3,0)
 ;;=3^Granular Dystrophy
 ;;^UTILITY(U,$J,358.3,8248,1,4,0)
 ;;=4^371.53
 ;;^UTILITY(U,$J,358.3,8248,2)
 ;;=^52826
 ;;^UTILITY(U,$J,358.3,8249,0)
 ;;=371.54^^53^571^80
 ;;^UTILITY(U,$J,358.3,8249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8249,1,3,0)
 ;;=3^Lattice Dystrophy
 ;;^UTILITY(U,$J,358.3,8249,1,4,0)
 ;;=4^371.54
 ;;^UTILITY(U,$J,358.3,8249,2)
 ;;=^268986
 ;;^UTILITY(U,$J,358.3,8250,0)
 ;;=371.55^^53^571^82
